Literature DB >> 33472035

AAV Joins the Rank of Genotoxic Vectors.

Utpal P Davé1, Kenneth Cornetta2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33472035      PMCID: PMC7854348          DOI: 10.1016/j.ymthe.2021.01.007

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  5 in total

1.  Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genome.

Authors:  Grant J Logan; Allison P Dane; Claus V Hallwirth; Christine M Smyth; Emilie E Wilkie; Anais K Amaya; Erhua Zhu; Neeta Khandekar; Samantha L Ginn; Sophia H Y Liao; Sharon C Cunningham; Natsuki Sasaki; Martí Cabanes-Creus; Patrick P L Tam; David W Russell; Leszek Lisowski; Ian E Alexander
Journal:  Nat Genet       Date:  2017-06-19       Impact factor: 38.330

2.  Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models.

Authors:  Randy J Chandler; Mark S Sands; Charles P Venditti
Journal:  Hum Gene Ther       Date:  2017-04       Impact factor: 5.695

3.  Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors.

Authors:  A Donsante; C Vogler; N Muzyczka; J M Crawford; J Barker; T Flotte; M Campbell-Thompson; T Daly; M S Sands
Journal:  Gene Ther       Date:  2001-09       Impact factor: 5.250

4.  A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells.

Authors:  Giang N Nguyen; John K Everett; Samita Kafle; Aoife M Roche; Hayley E Raymond; Jacob Leiby; Christian Wood; Charles-Antoine Assenmacher; Elizabeth P Merricks; C Tyler Long; Haig H Kazazian; Timothy C Nichols; Frederic D Bushman; Denise E Sabatino
Journal:  Nat Biotechnol       Date:  2020-11-16       Impact factor: 54.908

5.  Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease.

Authors:  Yedda Li; Christopher A Miller; Lauren K Shea; Xuntian Jiang; Miguel A Guzman; Randy J Chandler; Sai M Ramakrishnan; Stephanie N Smith; Charles P Venditti; Carole A Vogler; Daniel S Ory; Timothy J Ley; Mark S Sands
Journal:  Mol Ther       Date:  2021-01-01       Impact factor: 11.454

  5 in total
  7 in total

Review 1.  Cryo-electron Microscopy of Adeno-associated Virus.

Authors:  Scott M Stagg; Craig Yoshioka; Omar Davulcu; Michael S Chapman
Journal:  Chem Rev       Date:  2022-05-16       Impact factor: 72.087

2.  Liver gene therapy and hepatocellular carcinoma: A complex web.

Authors:  Ype P de Jong; Roland W Herzog
Journal:  Mol Ther       Date:  2021-03-19       Impact factor: 11.454

Review 3.  Delivering AAV to the Central Nervous and Sensory Systems.

Authors:  Cole W Peters; Casey A Maguire; Killian S Hanlon
Journal:  Trends Pharmacol Sci       Date:  2021-04-13       Impact factor: 17.638

4.  Delivery of non-viral naked DNA vectors to liver in small weaned pigs by hydrodynamic retrograde intrabiliary injection.

Authors:  Tatjana Chan; Hiu Man Grisch-Chan; Philipp Schmierer; Ulrike Subotic; Nicole Rimann; Tanja Scherer; Udo Hetzel; Matthias Bozza; Richard Harbottle; James A Williams; Barbara Steblaj; Simone K Ringer; Johannes Häberle; Xaver Sidler; Beat Thöny
Journal:  Mol Ther Methods Clin Dev       Date:  2022-01-19       Impact factor: 6.698

5.  Stronger together: Analytical techniques for recombinant adeno associated virus.

Authors:  Andrei Hutanu; David Boelsterli; Claudio Schmidli; Cristina Montealegre; Mike H N Dang Thai; Balazs Bobaly; Marius Koch; Maria A Schwarz
Journal:  Electrophoresis       Date:  2021-12-10       Impact factor: 3.595

6.  Ethical Perspectives on Treatment Options with Spinal Muscular Atrophy Patients.

Authors:  Crystal J J Yeo; Zachary Simmons; Darryl C De Vivo; Basil T Darras
Journal:  Ann Neurol       Date:  2022-01-25       Impact factor: 11.274

7.  Leveraging gene therapy to achieve long-term continuous or controllable expression of biotherapeutics.

Authors:  Timothy P Cripe; Brian Hutzen; Mark A Currier; Chun-Yu Chen; Andrea M Glaspell; Grace C Sullivan; Julia M Hurley; Mackenzie R Deighen; Akila S Venkataramany; Xiaokui Mo; Joseph R Stanek; Anthony R Miller; Saranga Wijeratne; Vincent Magrini; Elaine R Mardis; Jerry R Mendell; Dawn S Chandler; Pin-Yi Wang
Journal:  Sci Adv       Date:  2022-07-13       Impact factor: 14.957

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.